Risk Prediction is Improved by Adding Markers of Subclinical Organ Damage to SCORE
Overview
Authors
Affiliations
Aims: It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects.
Methods And Results: In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% CI 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR > or = 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE > or = 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE > or = 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE > or = 5% to include subjects with 1% < or = SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07).
Conclusion: Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.
Aortic-Femoral Stiffness Gradient and Cardiovascular Risk in Older Adults.
Stone K, Fryer S, McDonnell B, Meyer M, Faulkner J, Agharazii M Hypertension. 2024; 81(12):e185-e196.
PMID: 39371003 PMC: 11578793. DOI: 10.1161/HYPERTENSIONAHA.124.23392.
Anfaiha-Sanchez M, Santiago-Hernandez A, Lopez J, Lago-Baameiro N, Pardo M, Martin-Blazquez A J Extracell Biol. 2024; 3(9):e170.
PMID: 39290459 PMC: 11406310. DOI: 10.1002/jex2.170.
Hypertension in children and adolescents: perspectives in Japan.
Fujiwara T, Kaneko H, Hayashi K, Azegami T, Mizuno A, Yano Y Hypertens Res. 2024; 47(12):3372-3379.
PMID: 39256527 DOI: 10.1038/s41440-024-01870-w.
Estimated Pulse Wave Velocity and All-Cause and Cardiovascular Mortality in the General Population.
Prelevic V, Blagus L, Bosnjak V, Radunovic D, Marinovic Glavic M, Premuzic V J Clin Med. 2024; 13(12).
PMID: 38929906 PMC: 11204842. DOI: 10.3390/jcm13123377.
Alves-Cabratosa L, Elosua-Bayes M, Marti-Lluch R, Blanch J, Tornabell-Noguera E, Garcia-Gil M J Atheroscler Thromb. 2024; 31(5):626-640.
PMID: 38171907 PMC: 11079498. DOI: 10.5551/jat.64541.